1. Novel Immunotherapeutic Agents and Small Molecule Antagonists of Signalling Kinases for the Treatment of Metastatic Melanoma

   • Nagendra Natarajan
   • Sucheta Telang
   • Jason Chesney

   Leading Article 15 October 2012 Pages: 1233 - 1250

   

2. Cabazitaxel

   • Cristian Villanueva
   • Fernando Bazan
   • Xavier Pivot

   Leading Article 15 October 2012 Pages: 1251 - 1258

   

3. Topical Therapies for Osteoarthritis

   • Roy D. Altman
   • H. Richard Barthel

   Review Article 15 October 2012 Pages: 1259 - 1279

   

4. Erratum to: Aliskiren: a review of its use as monotherapy and as combination therapy in the management of hypertension

   • ST Duggan
   • CM Chwieduk
   • MP Curran

   Erratum 15 October 2012 Pages: 1280 - 1280

5. Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimer’s Disease

   • Garth J. S. Cooper

   Review Article 15 October 2012 Pages: 1281 - 1320

   

6. Eribulin

   • Caroline M. Perry

   Adis Drug Profile 15 October 2012 Pages: 1321 - 1331

   

7. Erratum to: Ranolazine: a review of its use in chronic stable angina pectoris

   • G. Keating

   Erratum 15 October 2012 Pages: 1332 - 1332

8. Eltrombopag

   • Karly P. Garnock-Jones

   Adis Drug Evaluation 15 October 2012 Pages: 1333 - 1353

   

9. Vandetanib

   • Helen Commander
   • Glenn Whiteside
   • Caroline Perry

   R&D Insight Profile 15 October 2012 Pages: 1355 - 1365